Evidence map›Paper›PMID 25334038›Full record

ReviewThe American journal of the medical sciences2015

Impact of vitamin D on infectious disease.

Malcolm D Kearns, Jessica A Alvarez, Natan Seidel, Vin Tangpricha

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The American journal of the medical sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06304948 (The Link Between Human Cytomegalovirus Gene Expression and Glutamate Levels in Migraine), which is not on this map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06304948 unknown statusnot on this mapstarted 2024, after this paper: background citation

The Link Between Human Cytomegalovirus Gene Expression and Glutamate Levels in Migraine :Relationship to the Vit D Deficiency

Typeobservational_patient_registrySponsorAssiut UniversityRan2024 to 2025Enrolled72ConditionsMigraine
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Vitamin DBMC infectious diseases · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Efficacy of vitamin DTrials · 2017
    Trial
  7. Article
  8. AnCurrent drug discovery technologies · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Are Low Serum Vitamin D Levels a Risk Factor for Advent of COVID-19 Associated Rhinocerebral Mucormycosis: A Preliminary Case Control Study.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  16. Review
  17. Vitamin therapy in sepsis.Pediatric research · 2022
    Review
  18. Article
  19. Article
  20. Hypovitaminosis D and Parathyroid Hormone Response in Critically Ill Children with Sepsis: A Case-control Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Malcolm D KearnsDivision of Endocrinology, Metabolism and Lipids (MDK, JAA, NS, VT), Emory University School of Medicine, Atlanta, Georgia; and Section of Endocrinology (VT), Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
Jessica A Alvarez
Natan Seidel
Vin Tangpricha
Emory University · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Integration of Nutritional Metabolomics with Bioenergetics in Cystic FibrosisK01DK102851 · NIDDK · EMORY UNIVERSITY · PI ALVAREZ, JESSICA ALEJANDRA · 2014 to 2018
$614k
NCATS NIH HHS UL1 TR000454NIDDK NIH HHS K01 DK102851
6 · The paper itself

Abstract

backgroundObservational studies have linked vitamin D status and infectious disease. This association is supported by the presence of the vitamin D receptor and CYP27B1 in immune cells. This review aims to consolidate data from clinical trials that used vitamin D for the treatment or prevention of infectious disease.

methodsThe authors searched the term "(vitamin D OR ergocalciferol OR cholecalciferol OR vitamin D2 OR vitamin D3 OR calcitriol) AND (infection OR tuberculosis OR sepsis OR pneumonia)" with limits preset to manuscripts published in English and with human subjects. They identified controlled trials that measured infectious outcomes (eg, incidence and severity of disease, time to disease resolution or recurrence, measures of clinical improvement, mortality). Studies that used analog, topical or micronutrient formulations of vitamin D, assessed only vitamin D status or lacked a comparison group were excluded. The references from eligible manuscripts and from 2 recent reviews were scanned for additional manuscripts.

resultsOne thousand two hundred eighty-four manuscripts were identified with our search terms, with 60 papers still eligible after review of the title and abstract. Full review of these papers, their references and 2 related reviews yielded 38 manuscripts.

conclusionsAlthough some prospective studies show positive results regarding vitamin D on infectious disease, several robust studies are negative. Factors such as high variability between studies, the difference in individual responsiveness to vitamin D and study designs that do not primarily investigate infectious outcomes may mask the effects of vitamin D on infections.

Indexed as

Controlled Clinical Trials as TopicHumansRespiratory Tract InfectionsTuberculosisVitamin DVitaminsVitamin DVitamins

Identifiers

PMID25334038
PMCPMC4346469
OpenAlexW15726864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.